Illumina Can't Enforce Fetal DNA Testing Patent, Natera Says
Natera Inc. on Thursday asked a California federal court to free it from patent infringement litigation brought by competitor Illumina Inc., arguing the fetal DNA testing technology at issue isn't patent...To view the full article, register now.
Already a subscriber? Click here to view full article